GLP-1 safety trends and emerging side effects While gastrointestinal discomfort is the most common issue, new safety signals continue to emerge
Supergut Supergut is approaching the market from the metabolic health side rather than traditional diet positioning
Recent developments: April 2026, The FDA proposed excluding semaglutide, tirzepatide, and liraglutide from the 503B bulks list, potentially limiting large-scale compounding activities
Compound exercises like squats, deadlifts, rows, presses, and lunges recruit large muscle groups and help stimulate the muscle tissue that supports strength and metabolism
If you are ready to quiet the food noise and take control of your health, the team at Aspire MedSpa is here to guide you through every phase of the process, ensuring your path to wellness is effective, monitored, and permanent
The development of Byetta (exenatide) from the venom of the Gila monster as an anti-diabetic agent